Inhibition of SYK and cSrc kinases can protect bone and cartilage in preclinical models of osteoarthritis and rheumatoid arthritis
Abstract The pathophysiology of osteoarthritis (OA) includes the destruction of subchondral bone tissue and inflammation of the synovium. Thus, an effective disease-modifying treatment should act on both of these pathogenetic components. It is known that cSrc kinase is involved in bone and cartilage...
Main Authors: | F. N. Novikov, M. V. Panova, I. Y. Titov, V. S. Stroylov, O. V. Stroganov, G. G. Chilov |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-11-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-02568-6 |
Similar Items
-
Author Correction: Inhibition of SYK and cSrc kinases can protect bone and cartilage in preclinical models of osteoarthritis and rheumatoid arthritis
by: F. N. Novikov, et al.
Published: (2022-10-01) -
Rapid Actions of the Nuclear Progesterone Receptor through cSrc in Cancer
by: Claudia Bello-Alvarez, et al.
Published: (2022-06-01) -
Differential Requirements for Src-Family Kinases in SYK or ZAP70-Mediated SLP-76 Phosphorylation in Lymphocytes
by: Frank Fasbender, et al.
Published: (2017-07-01) -
Glucosylceramide synthase upregulates <it>MDR1 </it>expression in the regulation of cancer drug resistance through <it>cSrc </it>and β-catenin signaling
by: Cabot Myles C, et al.
Published: (2010-06-01) -
Monovalent and Multivalent Ligation of the B Cell Receptor Exhibit Differential Dependence upon Syk and Src Family Kinases
by: Mukherjee, Sayak, et al.
Published: (2014)